SOLUTIONS AT THE
We are pioneering the discovery and development of novel patient-directed therapies targeting key signaling pathways that drive the formation and spread of disease.
Ion Biotechnology Aqueous Ligands
We create novel medicines that benefit individuals and society while bringing new scientific understanding to diseases.
Healthy aerobic cells which follow the full Krebs cycle should absorb the minerals that they need and reject the excess.
Anaerobic cells which follow a less complex metabolic pathway, non-Krebs metabolic cycle absorb enough metals to result in a lethal overdose.
Because viruses, bacteria, and fungi do not follow the complete metabolic cycle, IBAL technology can treat a variety of infections and indications.
IBAL is involved in every phase of the cell cycle.
We are involved in every stage of the process.
We create a systematically organized body of knowledge.OUR COMPANY